Vue transversale de la maladie
Myopathies
Un même point d’entrée pour les études cliniques, les découvertes scientifiques, les publications et les pistes exploratoires présentes dans Biomedical Watch.
Périmètre
Filtrer toute la vue
Chaque choix s’applique immédiatement aux quatre sections. Le filtre « type de SEP » n’apparaît que lorsque la sclérose en plaques est sélectionnée.
1012 résultats correspondants
· 46 visibles sur cette page
dans le périmètre Myopathies
Niveau clinique
Études et traitements 421
Interventions, programmes et essais cliniques rattachés au périmètre sélectionné.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Abdominal and Core Exercises on Respiratory Functions in Obese and Ov… NCT07103499 · NCT07103499 | Myopathies | À vérifier | Non applicable | COMPLETED | This study aims to examine the effects of an 8-week Pilates-based exercise… À vérifier | ClinicalTrials.gov 2026-09-14 15:37:00 | Détail |
| Da-Cheng-Qi Decoction Plus Standard Western Treatment NCT07816900 · Efficacy and Safety of Da-Cheng-Qi Decoction in Severe Acute Pancreatitis | Myopathies | Traitement symptomatique | Non applicable | COMPLETED | This single-center prospective randomized controlled trial evaluated Da-Ch… À vérifier | ClinicalTrials.gov 2026-09-14 15:37:00 | Détail |
| Data Collection of Standard Care of Patients in the EMG Section NCT05041387 · NCT05041387 | Myopathies | Traitement symptomatique · Thérapie génique | À vérifier | RECRUITING | Background: Most people who are referred to the EMG (Electromyography) Sec… À vérifier | ClinicalTrials.gov 2026-09-14 15:37:00 | Détail |
| Effects of Dry Needling on Electromyographic Activity and Ultrasonogr… NCT06017960 · NCT06017960 | Myopathies | Ralentissement de la progression · Traitement symptomatique · Thérapie génique | Non applicable | COMPLETED | Stroke is a global health problem, with an incidence in Europe of 147/100,… À vérifier | ClinicalTrials.gov 2026-09-14 15:37:00 | Détail |
| EXOPULSE Mollii Suit and EXOPULSE Suit NCT05901259 · EXOREG — The EXOPULSE Study - a Database for Routine Follow-up of Clinical Outco… | Myopathies | Traitement symptomatique | À vérifier | RECRUITING | The objective is to explore the potential short and long-term impact of th… À vérifier | ClinicalTrials.gov 2026-09-14 15:37:00 | Détail |
| FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyos… NCT07111065 · NCT07111065 | Myopathies | Traitement symptomatique | Phase 2 | RECRUITING | Dermatomyositis (DM) is a rare autoimmune disease that causes muscle weakn… À vérifier | ClinicalTrials.gov 2026-09-14 15:37:00 | Détail |
| Fibromyalgia-Related Quality of Life and Exercise Motivation NCT07777393 · NCT07777393 | Myopathies | À vérifier | À vérifier | COMPLETED | The objective of this study is to evaluate possible correlations between m… À vérifier | ClinicalTrials.gov 2026-09-14 15:37:00 | Détail |
| low-calorie low-protein NCT03573739 · NUTRIREA3 — Impact of Early Low-Calorie Low-Protein Versus Standard Feeding on O… | Myopathies | Thérapie génique | Non applicable | COMPLETED | Among critically ill patients requiring mechanical ventilation and catecho… À vérifier | ClinicalTrials.gov 2026-09-14 15:37:00 | Détail |
| Outcomes of Neurosurgical Tone Management NCT07817745 · NCT07817745 | Myopathies | Traitement symptomatique · Thérapie génique | À vérifier | RECRUITING | Patients with spastic/dystonic quadriplegia (GMFCS IV/V) are often severel… À vérifier | ClinicalTrials.gov 2026-09-14 15:37:00 | Détail |
| PF-08154225 NCT07782450 · A Study to Learn About a Medicine Called PF-08154225 in Participants With Autoim… | Myopathies | Immunomodulation · Thérapie génique | Phase 1/2 | NOT_YET_RECRUITING | The purpose of this study is to learn about the safety and effects of the… À vérifier | ClinicalTrials.gov 2026-09-14 15:37:00 | Détail |
| R01_Pilot Jaw Muscle Phenotypes NCT07153107 · NCT07153107 | Myopathies | Traitement symptomatique | Non applicable | NOT_YET_RECRUITING | The proposed study will assess the effect of local heat therapy on jaw pai… À vérifier | ClinicalTrials.gov 2026-09-14 15:37:00 | Détail |
| synovial biopsy NCT07503821 · SYVIPRO — Synovial Tissue as a Biomarker in the Management of Pigmented Villonod… | Myopathies | Immunomodulation · Traitement symptomatique | Non applicable | RECRUITING | Pigmented villonodular synovitis (PVNS) is a rare joint disease caused by… À vérifier | ClinicalTrials.gov 2026-09-14 15:37:00 | Détail |
| transcutaneous vagus nerve stimulation NCT06009159 · Vagus Nerve Stimulation(VNS) As Treatment For Fibromyalgia Patients | Myopathies | À vérifier | Non applicable | RECRUITING | Attaining goals or rewards commonly entails response costs. In light of co… À vérifier | ClinicalTrials.gov 2026-09-14 15:37:00 | Détail |
| Yangyin Roujin Decoction NCT07736144 · Mechanism Study of Yangyin Roujin Formula in the Treatment of Fibromyalgia Syndr… | Myopathies | Traitement symptomatique | Non applicable | RECRUITING | This prospective randomized, double-blind, controlled clinical trial is de… À vérifier | ClinicalTrials.gov 2026-09-14 15:37:00 | Détail |
| ABLE Kids NCT07745712 · Clinical Investigation to Validate the Safety and Performance of the ABLE Kids D… | Myopathies | À vérifier | Non applicable | RECRUITING | The primary objective of the study is to validate the safety and clinical… À vérifier | ClinicalTrials.gov 2026-09-14 12:37:06 | Détail |
| Active Coping: Interdisciplinary Program for Chronic Pain, Physiother… NCT07504094 · NCT07504094 | Myopathies | Traitement symptomatique | Non applicable | ACTIVE_NOT_RECRUITING | The goal of this observational intervention study is to evaluate the impac… À vérifier | ClinicalTrials.gov 2026-09-14 12:37:06 | Détail |
| AXS-14 (esreboxetine) NCT07637162 · Open-Label Safety Study of AXS-14 in Subjects With Fibromyalgia | Myopathies | À vérifier | Phase 3 | ENROLLING_BY_INVITATION | This is a Phase 3, multi-center, 52-week, open-label trial to evaluate the… À vérifier | ClinicalTrials.gov 2026-09-14 12:37:06 | Détail |
| AXS-14 (esreboxetine) NCT07398417 · FORWARD — Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized W… | Myopathies | À vérifier | Phase 3 | RECRUITING | This is a Phase 3, multi-center, 52-week, open-label trial to evaluate the… À vérifier | ClinicalTrials.gov 2026-09-14 12:37:06 | Détail |
| BMS-986368 NCT06782490 · MSS — A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in… | Myopathies | Traitement symptomatique | Phase 2 | RECRUITING | This is a study to evaluate the efficacy, safety, and tolerability of BMS-… À vérifier | ClinicalTrials.gov 2026-09-14 12:37:06 | Détail |
| Craniovertebral Angle and Fibromyalgia Severity NCT06957873 · NCT06957873 | Myopathies | Traitement symptomatique | À vérifier | RECRUITING | Forward Head Posture Frequency in Fibromyalgia Patients Assessed by Cranio… À vérifier | ClinicalTrials.gov 2026-09-14 12:37:06 | Détail |
Découverte scientifique
Recherches et trouvailles 0
Projets précliniques, publications émergentes et programmes de recherche suivis dans le pipeline.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Aucune trouvaille ne correspond aux filtres. | |||||||
Bibliographie
Publications 585
Références bibliographiques de la base locale et accès à leur source originale.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Identifying the Diagnostic Challenges and Indicators of Orthostatic T… Data Collection of Standard Care of Patients in the EMG Section · PMID 40265716 | Myopathies | Traitement symptomatique · Thérapie génique | Publication | PubMed | Voir la publication source The diagnosis of orthostatic tremor (OT) is challenging because of its non-specific symptoms and a broad range of diffe… | Movement disorders clinical practice 2026-08-13 15:03:20 | Source |
| Utilization of Preoperative Electrodiagnostic Studies for Carpal Tunn… Data Collection of Standard Care of Patients in the EMG Section · PMID 27068003 | Myopathies | À vérifier | Publication | PubMed | Voir la publication source Given the lack of a reference standard diagnostic tool for carpal tunnel syndrome (CTS), we conducted a population-leve… | The Journal of hand surgery 2026-08-13 15:03:20 | Source |
| Applicability of an Immersive Virtual Reality Exercise Training Syste… Dual-task cycling · PMID 35878115 | Myopathies | À vérifier | Publication | PubMed | Voir la publication source Virtual reality is a computer-generated simulation of a real or imaginary three-dimensional environment that has entere… | Sports (Basel, Switzerland) 2026-08-13 15:03:19 | Source |
| Event-related brain potentials reveal enhancing and compensatory mech… Dual-task cycling · PMID 37845733 | Myopathies | À vérifier | Publication | PubMed | Voir la publication source Various neurocognitive tests have shown that cycling enhances cognitive performance compared to resting. Event-related… | BMC sports science, medicine & rehabilitation 2026-08-13 15:03:19 | Source |
| Advancing treatment of spinal muscular atrophy through inhibition of… Apitegromab · PMID 41566720 | Myopathies | À vérifier | Publication | PubMed | Voir la publication source In spinal muscular atrophy (SMA), irreversible loss of spinal motor neurons and progressive skeletal muscle atrophy cau… | Expert review of neurotherapeutics 2026-08-13 15:03:18 | Source |
| Apitegromab for lean mass preservation during tirzepatide-induced wei… Apitegromab · PMID 42260100 | Myopathies | À vérifier | Publication | PubMed | Voir la publication source Loss of lean mass in proportion to total weight loss is observed with incretin mimetic therapies such as tirzepatide an… | Nature medicine 2026-08-13 15:03:18 | Source |
| Impact of Virtual Reality-Based Task-Oriented Training for Enhancing… Standard rehabilitation · PMID 42581516 | Myopathies | À vérifier | Publication | PubMed | Voir la publication source BACKGROUND Stroke frequently causes persistent motor impairment and dependence in activities of daily living (ADL). Vir… | Medical science monitor : international medical journa… 2026-08-13 15:03:17 | Source |
| The Role of Radial Shockwave Therapy in Reducing Spasticity and Impro… Standard rehabilitation · PMID 42589983 | Myopathies | Traitement symptomatique | Publication | PubMed | Voir la publication source : Spasticity resulting from a stroke usually develops within a few weeks or months of the incident and occurs in approx… | Journal of clinical medicine 2026-08-13 15:03:17 | Source |
| Exploring somatosensory temporal discrimination deficits in rheumatoi… Constant Current Stimulator · PMID 41316482 | Myopathies | Ralentissement de la progression | Publication | PubMed | Voir la publication source Objective- Somatosensory deficits in rheumatoid arthritis (RA) have not been adequately investigated, despite their pot… | Advances in rheumatology (London, England) 2026-08-13 15:03:15 | Source |
| Optimizing Movement Performance with Altered Sensation: An Examinatio… Constant Current Stimulator · PMID 37759903 | Myopathies | À vérifier | Publication | PubMed | Voir la publication source Two experiments were conducted to assess the impact of induced paresthesia on movement parameters of goal-directed aimi… | Brain sciences 2026-08-13 15:03:15 | Source |
| Degradation-Robust Hue Prior Network for Low-Light Rainy Image Restor… SRP-1003 SC Injection · PMID 42590629 | Myopathies | À vérifier | Publication | PubMed | Voir la publication source Restoring images captured in low-light rainy scenes is challenging because brightness degradation and rain corruption a… | Sensors (Basel, Switzerland) 2026-08-13 15:03:14 | Source |
| Elegans-Inspired Magnetic Polyurethane Soft Robot (MPSR) for Closed V… SRP-1003 SC Injection · PMID 42590852 | Myopathies | À vérifier | Publication | PubMed | Voir la publication source Secondary hemorrhage is inevitable during the transportation of casualties in harsh environments, and reoperative treat… | Advanced healthcare materials 2026-08-13 15:03:14 | Source |
| Remifentanil attenuates LPS-induced hepatic injury by modulating NRF2… SRP-1003 IV Infusion · PMID 42584673 | Myopathies | Neuroprotection · Immunomodulation · Thérapie génique | Publication | PubMed | Voir la publication source Lipopolysaccharide (LPS)-induced sepsis causes widespread inflammation and liver dysfunction, driven by oxidative stres… | Naunyn-Schmiedeberg's archives of pharmacology 2026-08-13 15:03:13 | Source |
| Transient Neonatal Myasthenia Gravis in a Newborn Infant Presenting t… SRP-1003 IV Infusion · PMID 42583073 | Myopathies | Thérapie génique | Publication | PubMed | Voir la publication source A four-day-old female born full term via uncomplicated vaginal delivery presented to the emergency department with poor… | Cureus 2026-08-13 15:03:13 | Source |
| AOC 1044 induces exon 44 skipping and restores dystrophin protein in… AOC 1044 · PMID 40183632 | Myopathies | À vérifier | Publication | PubMed | Voir la publication source Duchenne muscular dystrophy (DMD) is a severe disorder caused by mutations in the dystrophin gene, resulting in loss of… | Nucleic acids research 2026-08-13 15:03:12 | Source |
| Antibodies to watch in 2026. delpacibart zotadirsen · PMID 41560619 | Myopathies | À vérifier | Publication | PubMed | Voir la publication source The Antibodies to Watch article series provides annual updates on commercial late-stage clinical development, regulator… | mAbs 2026-08-13 15:03:10 | Source |
| A hospital based epidemiological study of genetically determined musc… 3 Year Follow up on ANO5 Patients · PMID 32146000 | Myopathies | Thérapie génique | Publication | PubMed | Voir la publication source We determined the prevalence of genetically determined neuromuscular diseases in adult Norwegian patients from Hordalan… | Neuromuscular disorders : NMD 2026-08-13 15:03:09 | Source |
| Clinical and genetic features of anoctaminopathy in Saudi Arabia. 3 Year Follow up on ANO5 Patients · PMID 25864073 | Myopathies | Ralentissement de la progression · Traitement symptomatique | Publication | PubMed | Voir la publication source Characterization of the phenotypic, pathological, radiological, and genetic findings in 2 Saudi Arabian families with a… | Neurosciences (Riyadh, Saudi Arabia) 2026-08-13 15:03:09 | Source |
| Individualized 3D-Printed Titanium Mesh-Assisted Alveolar Reconstruct… 3d printed Stabilization splint · PMID 42551905 | Myopathies | Remyélinisation indirecte / réparation | Publication | PubMed | Voir la publication source Medication-related osteonecrosis of the jaw is a severe complication of antiresorptive therapy that often necessitates… | The Journal of oral implantology 2026-08-13 15:03:08 | Source |
| Trueness and scanning time of complete-arch intraoral scans of edentu… 3d printed Stabilization splint · PMID 42521277 | Myopathies | À vérifier | Publication | PubMed | Voir la publication source This in vitro study evaluated the influence of the presence of saliva in varying levels on the trueness and scanning ti… | Journal of prosthodontics : official journal of the Am… 2026-08-13 15:03:08 | Source |
Exploration — prudence
Pistes exploratoires 6
Rapprochements mécanistiques et hypothèses de recherche : ils ne constituent pas une preuve d’efficacité ni une recommandation thérapeutique.
Hypothèses non validéesÀ confirmer par des travaux précliniques, cliniques et une revue scientifique indépendante.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| N-PPG N-PPG — modulation métabolique cérébrale | Myopathies | Remyélinisation indirecte / réparation · Neuroprotection | Hypothèse exploratoire | Rapprochement automatique non validé | Modulation métabolique et mitohormèse N-PPG est étudié dans Maladie de Huntington et documente plusieurs axes biologiques pouvant être pertinents pour Myopat… | Rapprochement Biomedical Watch · Maladie de Huntington | Détail |
| Vecteur Ple389 (ADORA2A) MiniPromoter Ple389 — ciblage striatal | Myopathies | Thérapie génique | Hypothèse exploratoire | Rapprochement automatique non validé | Expression génique ciblée dans les neurones striataux Vecteur Ple389 (ADORA2A) est étudié dans Maladie de Huntington et documente plusieurs axes biologiques pouvant être per… | Rapprochement Biomedical Watch · Maladie de Huntington | Détail |
| α-Amyrin α-Amyrin — protection mitochondriale | Myopathies | Remyélinisation indirecte / réparation · Neuroprotection | Hypothèse exploratoire | Rapprochement automatique non validé | Protection mitochondriale et modulation de la pathologie Tau α-Amyrin est étudié dans Maladie d’Alzheimer et documente plusieurs axes biologiques pouvant être pertinents pour Myopa… | Rapprochement Biomedical Watch · Maladie d’Alzheimer | Détail |
| 4-octyl itaconate et dérivés Dérivés de l’itaconate — neuroinflammation | Myopathies | Neuroprotection · Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | Modulation immunométabolique de la microglie 4-octyl itaconate et dérivés est étudié dans Sclérose latérale amyotrophique et documente plusieurs axes biologiques po… | Rapprochement Biomedical Watch · Sclérose latérale amy… | Détail |
| Thonningianin A Thonningianin A — neuroprotection anti-amyloïde | Myopathies | Neuroprotection | Hypothèse exploratoire | Rapprochement automatique non validé | Modulation du stress oxydatif et des protéines associées à Alzheimer Thonningianin A est étudié dans Maladie d’Alzheimer et documente plusieurs axes biologiques pouvant être pertinents pou… | Rapprochement Biomedical Watch · Maladie d’Alzheimer | Détail |
| Vutiglabridin Vutiglabridin — autophagie et PON2 | Myopathies | Neuroprotection | Hypothèse exploratoire | Rapprochement automatique non validé | Activation de PON2 et stimulation de l’autophagie Vutiglabridin est étudié dans Maladie d’Alzheimer et documente plusieurs axes biologiques pouvant être pertinents pour… | Rapprochement Biomedical Watch · Maladie d’Alzheimer | Détail |